COVID-19 Outbreak-Global Myasthenia Gravis Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Aug 2020 | Page 110
Myasthenia gravis (MG) is an autoimmune disease caused by dysfunction of the nerve-muscle junction. The clinical manifestations are partial or systemic skeletal muscle weakness and fatigue. After the activity, the....
COVID-19 Outbreak-Global Ashwagandha Extract Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Aug 2020 | Page 108
The Ashwagandha Extract market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this....
COVID-19 Outbreak-Global Technetium-99m Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Aug 2020 | Page 114
Technetium-99m is a medical radioisotope and used in gamma camera and SPECT for body imaging. SPECT is a highly sensitive technique to detect the parathyroid adenomas in the human body.....
COVID-19 Outbreak-Global R-Salbutamol Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Aug 2020 | Page 121
Salbutamol is a short-acting, selective beta2-adrenergic receptor agonist used in the treatment of asthma and COPD. It is 29 times more selective for beta2 receptors than beta1 receptors giving it....
COVID-19 Outbreak-Global Botulinum Toxins Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Aug 2020 | Page 114
Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species.It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction....
